Close
American Drug Delivery & Formulation Summit
Xylem

Press Releases

Promega Corporation and FUJIFILM Cellular Dynamics Announce Strategic Collaboration to Advance Novel Assay Development

Promega Corporation (Promega), a leader in providing innovative solutions and?technical support?to the life sciences industry, and FUJIFILM Cellular Dynamics, Inc., a leading global developer and manufacturer of human induced pluripotent stem cell (iPSC) technologies, today announced a strategic collaboration...

AbbVie and Gedeon Richter Announce Collaboration in Neuropsychiatric Diseases

AbbVie and Gedeon Richter Plc. announced a new co-development and license agreement to research, develop and commercialize novel dopamine receptor modulators for the potential treatment of neuropsychiatric diseases. The collaboration is based on the results of preclinical research carried...

Stevanato Group to Create Manufacturing Hub in China

Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced the acquisition of a facility in Zhangjiagang for a new plant where the Company expects to begin...

Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions

Molecular Health and collaborators at the University of Florida College of Pharmacy, Takeda Oncology, and thinkQ2 published a triad of articles that describe and prove the concept of a novel systems approach to elucidate molecular mechanisms of drug toxicities...

Envirotainer and Swiss WorldCargo complete the first commercial shipment using the new Releye RAP

Envirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, announced that the first commercial shipment using the new Releyeยฎ RAP container has been completed. The consignment was handled by Swiss WorldCargo, one of...

Oragenics Engages KBI Biopharma to Support Development of Intranasal COVID-19 Vaccine Candidate NT-CoV2-1

Oragenics, Inc. announced it has entered into an agreement with KBI Biopharma, Inc. for the process transfer, process optimization and cGMP manufacturing of the Companyโ€™s intranasal vaccine candidate NT-CoV2-1, which is expressed in a proprietary CHO cell line. The...

WuXi ATU Announces Launch of TESSA Technology to Improve Scalability and Accessibility of Cell and Gene Therapies

WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSAโ„ข). This technology is a state-of-the-art novel process for transfection-free, scalable manufacture of adeno-associated virus (AAV) at Good Manufacturing Practice...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป